Fig. 2.

Comparisons of the ratio of VEGF-A₁₆₅b to total VEGF-A according to the incidence of major adverse cardiac and cerebrovascular events (MACCEs), and cumulative incidence of MACCEs according to the cut-off value of the ratio at day 3 (A) and 30 (B) after PCI. The Kaplan-Meier analysis was performed to evaluate the cumulative incidence of MACCEs, and comparisons were assessed using the log-rank test. The values of median (interquartile range) in patients with and without MACCEs were as follows: A. Patients without MACCEs: 0.25 (0.21–0.56), Patients with MACCEs: 0.70 (0.36–0.91). B. Patients without MACCEs: 0.36 (0.24–0.52), Patients with MACCEs: 0.64 (0.57–0.93). ^⁎p < 0.05 (Mann Whitney U test).